China’s Booming Biotech IPOs

We have earlier commented on the sharply accelerated venture capital activity in the biotech sector in China. From around 2-3 deals a month, aggregating maybe USD100m 2-3 years ago, China is now witnessing close to USD1B of venture capital investments in biotech sector on a  monthly basis. Keeping company is…

Read More

Covid-19 vaccine pipeline expands to 13 at clinical stage

Furious activity is on around the world to come up with a vaccine for the Covid-19 virus. The stakes are high, not just in human life saving imperative, but also likely financial rewards to the company that is first off the block. The active pipeline, as document by the World…

Read More

Sushant Singh’s death underscores need for mental health startups

An extremely unfortunate event unfolded on Sunday, when established Bollywood movie star Sushant Singh Rajput committed suicide, purportedly from depression. This brought out in stark relief the scourge of mental illness, of which depression is the most common form. That such a successful person, with no monetary problems, can fall…

Read More

China’s monthly biotech investments headed towards USD1B+ consistently

Earlier this week we wrote how on 2 consecutive months, China’s biotech sector had witnessed more than USD1B of venture capital investment. That chart ignored another source of risk capital – IPOs. China has been producing around 1 biotech IPO a month consistently. These are typically pre-revenue R&D companies, but…

Read More

China’s supercharged biotech investment momentum continues in May’20

For the second month in a row, China’s biotech companies attracted more than USD1B of venture capital investment. Biotech investments crossed USD1B for the first time in April’20. Hence, May is the second consecutive month where VC/PE investments in biotech have crossed USD1B. In terms of amout invested, China inching…

Read More